Abstract
Bullous mastocytosis is a very rare variant of cutaneous mastocytosis. The condition is characterized by a diffuse infiltration of the skin by mast cells manifesting as yellowish, thickened doughy skin with appearance of large blisters. The authors report herewith a 7-month-old female infant with history of recurrent episodes of vesiculobullous lesions on the face, trunk and the extremities and excessive tendency to rub and scratch the skin for 3 months. She also had recurrent episodes of facial flushing. On cutaneous examination there were multiple flaccid bullae, urticarial wheals and crusted erosions on her scalp, face, neck, trunk and extremities. She had generalised yellowish thick and rough skin, giving doughy feel and ‘peaud orange’ appearance of the skin at places. Systemic examination was within normal limits. Skin biopsy from a lesion showed subepidermal bulla and an upper dermal inflammatory infiltrate comprising of lymphocytes and many mast cells. Toluidine blue staining of the cells showed presence of metachromatic granules in these cells. A diagnosis of bullous mastocytosis was made and the patient was treated with oral antihistamines to which there was no satisfactory response. Betamethasone in a dose of 0.1 mg/kg/day given orally caused complete remission of the disease in 4 weeks. The drug was gradually tapered and stopped over the next 6 weeks. There were no side effects of the therapy.
References
Warin RP, Hughes RCW. Diffuse cutaneous mastocytosis. BrJ Dermatol 1963; 65: 296–297.
Milton O, Robert AG, Carlyle CCet al. Bullous mastocytosis.Arch Dermatol 1970; 101: 547–562.
Hartman K, Henz BM. Mastocytosis: recent advances in defining the disease.Br J Dermatol 2001; 144: 682–695.
Murphy M, Walsh D, Drumm Bet al. Bullous mastocytosis: a fatal outcome.Pediatr Dermatol 1999; 16: 452–455.
Cook J, Stith M, Sahn EE. Bullous mastocytosis in an infant associated with the use of a nonprescription cough suppressant.Pediatr Dermatol 1996; 13:410–414.
Shah PY, Sharma V, Worobec ASet al. Congenital bullous mastocytosis with myeloproliferative disorder and c-kit mutation.J Am Acad Dermatol 1998; 39:119–121.
Gerrard JW. Urticaria pigmentoga: treated with cimetidine and chlorpheniramine.J Paediatr 1979; 94: 843–844.
Soter NA, Austen KF, Wasserman SI. Oral disodium cromoglycate in the teatment of systemic mastocytosis.N Engl J Med 1979; 301: 465–469.
Evans S, Vickers CFH. Bullous urticaria pigmentosa (cutaneous) and sodium cromoglycate.Acta Dermatol Venereol 1981; 61: 572–575.
Mackie S, Pride HB, Tyler WBet al. Diffuse cutaneous mastocytosis: treatment with oral psoralens plus UV-A.Arch Dermatol 1996; 132:1429–1430.
Vella Briffa D, Eady RAJ, James MPet al. Photochemotherapy (PUVA) in the treatment of urticaria pigmentosa.Br J Dermatol 1983; 109:67–75.
Crawhall IC, Wiskinson RD. Systemic mastocytosis: management of an unusual case with histamine (H1 and H2) antagonists and cyclooxygenase inhibition.Clin Invest Med 1987; 10: 1–4.
Delaporte E, Pierard E, Wolthers BGet al. Interferon-alpha in combination with corticosteroids improves systemic mast cell disease.Br J Dermatol 1995; 132: 479–482.
Barton J, Lavker RM, Schechter NM, Lazarus GS. Treatment of urticaria pigmentosa with corticosteroids.Arch Dermatol 1985; 121: 1516–1523.
Guzzo C, Lavker R, Rosert LJet al. Urticaria pigmentosa: systemic evaluation and successful treatment with topical steroids.Arch Dermatol 1991; 127:191–196.
Blauvelt A, Kerdel FA. Intravenous corticosteroids for systemic mastocytosis.Arch Dermatol 1991; 127:191–196.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Verma, K.K., Bhat, R. & Singh, M.K. Bullous mastocytosis treated with oral betamethasone therapy. Indian J Pediatr 71, 261–263 (2004). https://doi.org/10.1007/BF02724280
Issue Date:
DOI: https://doi.org/10.1007/BF02724280